27830025|t|Sevoflurane postconditioning improves myocardial mitochondrial respiratory function and reduces myocardial ischemia - reperfusion injury by up-regulating HIF-1
27830025|a|Sevoflurane postconditioning (SPostC) can exert myocardial protective effects similar to ischemic preconditioning. However, the exact myocardial protection mechanism by SPostC is unclear. Studies indicate that hypoxia-inducible factor-1 (HIF-1) maintains cellular respiration homeostasis by regulating mitochondrial respiratory chain enzyme activity under hypoxic conditions. This study investigated whether SPostC could regulate the expression of myocardial HIF-1α and to improve mitochondrial respiratory function, thereby relieving myocardial ischemia - reperfusion injury in rats. The myocardial ischemia - reperfusion rat model was established using the Langendorff isolated heart perfusion apparatus. Additionally, postconditioning was performed using sevoflurane alone or in combination with the HIF-1α inhibitor 2-methoxyestradiol (2ME2). The changes in hemodynamic parameters, HIF-1α protein expression levels, mitochondrial respiratory function and enzyme activity, mitochondrial reactive oxygen species (ROS) production rates, and mitochondrial ultrastructure were measured or observed. Compared to the ischemia - reperfusion (I / R) group, HIF-1α expression in the SPostC group was significantly up-regulated. Additionally, cardiac function indicators, mitochondrial state 3 respiratory rate, respiratory control ratio (RCR), cytochrome C oxidase (CcO), NADH oxidase (NADHO), and succinate oxidase (SUCO) activities, mitochondrial ROS production rate, and mitochondrial ultrastructure were significantly better than those in the I / R group. However, these advantages were completely reversed by the HIF-1α specific inhibitor 2ME2 (P<0.05). The myocardial protective function of SPostC might be associated with the improvement of mitochondrial respiratory function after up-regulation of HIF-1α expression.
27830025	0	11	Sevoflurane	T109,T121	C0074414
27830025	0	28	Sevoflurane postconditioning	T061	C0087111
27830025	29	37	improves	T033	C0184511
27830025	38	48	myocardial	T024	C0027061
27830025	49	62	mitochondrial	T026	C0026237
27830025	63	83	respiratory function	T043	C0282636
27830025	88	95	reduces	T080	C0392756
27830025	96	115	myocardial ischemia	T047	C0151744
27830025	118	136	reperfusion injury	T037	C0035126
27830025	140	153	up-regulating	T044	C0041904
27830025	154	159	HIF-1	T116,T123	C0215848
27830025	160	171	Sevoflurane	T109,T121	C0074414
27830025	160	188	Sevoflurane postconditioning	T061	C0087111
27830025	190	196	SPostC	T061	C0087111
27830025	208	218	myocardial	T024	C0027061
27830025	219	229	protective	T033	C1545588
27830025	230	237	effects	T080	C1280500
27830025	249	273	ischemic preconditioning	T061	C2936234
27830025	294	304	myocardial	T024	C0027061
27830025	305	315	protection	T033	C1545588
27830025	316	325	mechanism	T169	C0441712
27830025	329	335	SPostC	T061	C0087111
27830025	348	355	Studies	T062	C2603343
27830025	370	396	hypoxia-inducible factor-1	T116,T123	C0215848
27830025	398	403	HIF-1	T116,T123	C0215848
27830025	415	435	cellular respiration	T043	C0282636
27830025	436	447	homeostasis	T038	C0019868
27830025	462	475	mitochondrial	T026	C0026237
27830025	476	493	respiratory chain	T044	C0162362
27830025	494	509	enzyme activity	T044	C0243102
27830025	516	534	hypoxic conditions	T046	C0242184
27830025	541	546	study	T062	C2603343
27830025	547	559	investigated	T169	C1292732
27830025	568	574	SPostC	T061	C0087111
27830025	594	604	expression	T045	C1171362
27830025	608	618	myocardial	T024	C0027061
27830025	619	625	HIF-1α	T116,T123	C0965644
27830025	633	640	improve	T033	C0184511
27830025	641	654	mitochondrial	T026	C0026237
27830025	655	675	respiratory function	T043	C0282636
27830025	695	714	myocardial ischemia	T047	C0151744
27830025	717	735	reperfusion injury	T037	C0035126
27830025	739	743	rats	T015	C0034721
27830025	749	768	myocardial ischemia	T047	C0151744
27830025	771	782	reperfusion	T037	C0035126
27830025	783	786	rat	T015	C0034721
27830025	787	792	model	T008	C0599779
27830025	819	865	Langendorff isolated heart perfusion apparatus	T059	C4042864
27830025	881	897	postconditioning	T061	C0087111
27830025	918	929	sevoflurane	T109,T121	C0074414
27830025	963	969	HIF-1α	T116,T123	C0965644
27830025	970	979	inhibitor	T080	C1999216
27830025	980	998	2-methoxyestradiol	T109,T121	C0046319
27830025	1000	1004	2ME2	T109,T121	C0046319
27830025	1022	1033	hemodynamic	T042	C0019010
27830025	1034	1044	parameters	T077	C0549193
27830025	1046	1052	HIF-1α	T116,T123	C0965644
27830025	1053	1071	protein expression	T045	C1171362
27830025	1072	1078	levels	T080	C0441889
27830025	1080	1093	mitochondrial	T026	C0026237
27830025	1094	1114	respiratory function	T043	C0282636
27830025	1119	1134	enzyme activity	T044	C0243102
27830025	1136	1149	mitochondrial	T026	C0026237
27830025	1150	1173	reactive oxygen species	T123,T196	C0162772
27830025	1175	1178	ROS	T123,T196	C0162772
27830025	1180	1190	production	T038	C0220781
27830025	1191	1196	rates	T081	C1521828
27830025	1202	1215	mitochondrial	T026	C0026237
27830025	1216	1230	ultrastructure	T078	C0041623
27830025	1236	1244	measured	T080	C0444706
27830025	1248	1256	observed	T169	C1441672
27830025	1258	1266	Compared	T052	C1707455
27830025	1274	1282	ischemia	T047	C0151744
27830025	1285	1296	reperfusion	T037	C0035126
27830025	1298	1299	I	T047	C0151744
27830025	1302	1303	R	T037	C0035126
27830025	1305	1310	group	T078	C0441833
27830025	1312	1318	HIF-1α	T116,T123	C0965644
27830025	1319	1329	expression	T045	C1171362
27830025	1337	1343	SPostC	T061	C0087111
27830025	1344	1349	group	T078	C0441833
27830025	1368	1380	up-regulated	T044	C0041904
27830025	1396	1412	cardiac function	T042	C0232164
27830025	1425	1438	mitochondrial	T026	C0026237
27830025	1439	1458	state 3 respiratory	T043	C0282636
27830025	1459	1463	rate	T081	C1521828
27830025	1465	1490	respiratory control ratio	T081	C0456603
27830025	1492	1495	RCR	T081	C0456603
27830025	1498	1518	cytochrome C oxidase	T116,T126	C0010760
27830025	1520	1523	CcO	T116,T126	C0010760
27830025	1526	1538	NADH oxidase	T116,T126	C0131722
27830025	1540	1545	NADHO	T116,T126	C0131722
27830025	1552	1569	succinate oxidase	T116,T126	C0075423
27830025	1571	1575	SUCO	T116,T126	C0075423
27830025	1577	1587	activities	T044	C0243102
27830025	1589	1602	mitochondrial	T026	C0026237
27830025	1603	1606	ROS	T123,T196	C0162772
27830025	1607	1617	production	T038	C0220781
27830025	1618	1622	rate	T081	C1521828
27830025	1628	1641	mitochondrial	T026	C0026237
27830025	1642	1656	ultrastructure	T078	C0041623
27830025	1701	1702	I	T047	C0151744
27830025	1705	1706	R	T037	C0035126
27830025	1707	1712	group	T078	C0441833
27830025	1772	1778	HIF-1α	T116,T123	C0965644
27830025	1788	1797	inhibitor	T080	C1999216
27830025	1798	1802	2ME2	T109,T121	C0046319
27830025	1817	1827	myocardial	T024	C0027061
27830025	1828	1838	protective	T033	C1545588
27830025	1851	1857	SPostC	T061	C0087111
27830025	1887	1898	improvement	T077	C2986411
27830025	1902	1915	mitochondrial	T026	C0026237
27830025	1916	1936	respiratory function	T043	C0282636
27830025	1960	1966	HIF-1α	T116,T123	C0965644
27830025	1967	1977	expression	T045	C1171362